You are here: Industry Insights > DKD

News List

Diabetes treatment lowers PromarkerD risk score for diabetic kidney disease prnasia
August 13, 2021
Treatment with diabetes drug canagliflozin lowers the PromarkerD risk score for developing diabetic kidney disease in patients with type 2 diabetes, latest research suggests.
Four in 10 Diabetes Patients Have Kidney Disease drugs
June 24, 2021
More than four in 10 patients with diabetes have diabetic kidney disease (DKD), according to a study published online June 14 in BMJ Open Diabetes Research & Care.
FDA Approves New Kyprolis, Darzalex Combination Regimen americanpharmaceuticalreview
August 25, 2020
Amgen announced the U.S. Food and Drug Administration (FDA) has approved the expansion of the Kyprolis® (carfilzomib) U.S. prescribing information to include its use in combination with Darzalex® (daratumumab) plus dexamethasone (DKd) in two dosing ...
Precision Diabetes, LLC, Presents Data on Novel, Predictive Tests for Diabetes Complications at American Diabetes Association (ADA) Research Symposium: Advancing Precision Diabetes Medicine En-CPhI.CN
October 10, 2019
Precision Diabetes, LLC, an emerging leader in precision diabetes diagnostics, announced results today from two landmark diabetes studies on its predictive tests for kidney and cardiovascular complications of diabetes.